Golden Helix · Clinical Genomics Guide
NGS Analysis Software
What to Look For
A buyer-side guide for clinical lab directors and bioinformatics managers. Six pillars for evaluating clinical NGS platforms, how clinical-grade software differs from research tools, and the per-sample-tax trap to avoid.
Introduction
Software is the operational backbone
of clinical genomics.
The market for NGS analysis software is vast, ranging from open-source command-line tools to comprehensive clinical platforms. For labs moving into production-scale testing, the challenge is not just "finding variants." It is building a reproducible, validated, and automated workflow that holds up under CAP/CLIA inspection.
This guide outlines the six core pillars of professional NGS software evaluation: annotation breadth and currency, clinical interpretation, workflow automation, enterprise scalability, regulatory pedigree, and pricing model. Together they determine your lab's diagnostic yield, turnaround time, and operational scale.
Evaluation Framework
The Six Pillars
Each of these is a real differentiator between clinical-grade platforms and tools that will struggle in a production lab. Use them as the structure for a vendor RFI, an internal evaluation rubric, or a paid-pilot scorecard.
Pillar 1
Annotation Breadth & Currency
Your software is only as good as the data it draws on. Look for monthly curated updates to ClinVar, gnomAD, OMIM, ClinGen, and specialty databases for CNVs, structural variants, and pharmacogenomics. Annotation database versioning must be tracked and auditable for CAP/CLIA compliance.
Pillar 2
Clinical Interpretation Engine
Automated, guideline-driven scoring for ACMG/AMP (germline) and AMP/ASCO/CAP (somatic). The platform should systematically apply criteria to surface a suggested classification while leaving the reviewer in control to adjust criteria and document professional judgment. A classification engine, not a literature-review tool.
Pillar 3
Workflow Automation
From sequencer output to draft report without manual touchpoints. Robust API support, command-line execution, automated QC gating, and parallel processing across compute nodes are essential for scaling lab volume beyond a few cases per week.
Pillar 4
Enterprise Scalability
Multi-user environments with role-based access control. Variant assessment sharing through a knowledgebase so the same variant is never interpreted twice. Flexible deployment options: on-premises, private cloud, or air-gapped, depending on institutional data sovereignty requirements.
Pillar 5
Regulatory Pedigree
Software developed under an ISO 13485-certified Quality Management System. Determinism (same input, same output, every time), comprehensive audit trail, controlled release process, and electronic record controls designed to support CAP, CLIA, and 21 CFR Part 11 requirements.
Pillar 6
Transparent Pricing
Predictable, per-seat or enterprise licensing. Avoid "per-sample" pricing that penalizes the lab for successful growth and creates a tax on every additional case. Pricing should let you forecast software cost independently of throughput.
Tooling Tiers
Open Source vs Sequencer Software vs Clinical Platforms
Three broad tiers of NGS tooling exist. Each has its place. The fit depends on what the lab is trying to accomplish, the regulatory environment, and how much of the operational burden the lab wants to carry directly.
| Feature | Open Source / Scripts | Sequencer Software | Clinical Platform (e.g. VarSeq) |
|---|---|---|---|
| Annotation sourcing | Manual downloads, manual maintenance | Vendor-bundled static catalogs | Monthly curated, automated updates |
| Variant types covered | Mostly SNV / indel | Vendor-specific optimizations | SNV, indel, CNV, SV, PGx, HLA |
| Clinical scoring | External websites, manual scoring | Limited built-in support | Integrated ACMG/AMP automation |
| Data sovereignty | Depends on server | Often cloud-only (SaaS) | Full on-prem or private cloud |
| Reporting | Custom scripts, Excel exports | Template-based fixed output | Clinical-grade PDF, configurable |
| Quality system | None (research tools) | Varies by vendor | ISO 13485-certified QMS |
The right answer for a research group is often open-source. The right answer for a single-vendor lab tied to one sequencer is often the sequencer-provided software. The right answer for a clinical lab running production diagnostics across multiple assays is a purpose-built clinical platform. The honest framing is matching tier to need, not pretending one tier fits everyone.
ROI
Quantifying the Automation Advantage
The ROI of professional variant analysis software is not just the license cost. It is the hundreds of hours saved by the clinical team every month, and the consistency that comes from systematic evidence gathering rather than manual database queries.
| Approach | WES case review | What the workflow looks like |
|---|---|---|
| Manual spreadsheet workflow | ~120 min | External database queries, manual ACMG application, manual report assembly. |
| Automated platform (e.g. VarSeq) | ~15 min | Pre-aggregated evidence, automated ACMG scoring, pre-populated report templates. Reviewer validates and signs out. |
Practical Tool
The Buyer's Evaluation Checklist
Six questions to ask any vendor before signing an evaluation agreement. The answers map directly to the six pillars above and distinguish clinical-grade platforms from research tools.
- 01
Curated clinical databases included
Does the platform provide automated access to ClinVar, gnomAD, OMIM, ClinGen, HGMD, COSMIC, and SpliceAI, with versioning visible in every result? A platform that requires you to manage these yourself is a research tool, not a clinical platform.
- 02
CNV and SV without separate tooling
Can the platform detect and interpret CNVs and structural variants natively, or does it require a second-system handoff? A separate tool for CNVs creates audit-trail fragmentation and validation overhead.
- 03
Deterministic and reproducible across versions
Will the same VCF input produce the same annotated, filtered, classified output every time, on every machine? Any algorithm with random sampling, stochastic behavior, or unlocked version dependencies fails CAP/CLIA reproducibility requirements.
- 04
ISO 13485-certified QMS and audit-ready documentation
Does the vendor operate under a formal quality management system with controlled releases, change management, and complete audit trails? CAP inspectors expect this from clinical software vendors.
- 05
Deployment that respects data sovereignty
Can the platform be kept entirely behind the laboratory firewall, or in a cloud region you control? Institutional policy or GDPR may prohibit multi-tenant SaaS for genomic PHI.
- 06
Licensing that does not penalize growth
Is the model per-seat or fixed enterprise, rather than per-sample? Per-sample pricing makes financial planning impossible and discourages labs from running larger, more comprehensive tests.
Platform Ecosystem
The Golden Helix Stack
Instead of a collection of disconnected NGS analysis tools, Golden Helix provides a unified platform where secondary analysis, tertiary analysis, and data management work as one. Three products, one workflow.
Secondary analysis
Sentieon
High-performance alignment and variant calling, mathematically identical to GATK but optimized for speed and enterprise reliability. The secondary analysis engine that pairs naturally with VarSeq tertiary analysis.
Tertiary analysis
VarSeq + VSClinical
The core platform for tertiary analysis. VSClinical provides guideline-driven ACMG/AMP interpretation and clinical reporting, with automated evidence gathering, phenotype-driven prioritization, and human-in-the-loop reviewer control.
Data management
VSWarehouse
Enterprise variant data management for multi-user labs and multi-site programs. Centralized assessment catalogs, internal allele frequency tracking, reclassification monitoring, and LIMS/EHR integration. Deployed on-premises or in your own cloud.
Common Questions
Software Evaluation FAQ
How do I choose between cloud-based and on-premises NGS software?
Is open-source software suitable for clinical use?
What is the "per-sample tax" and why does it matter?
How often should NGS annotation databases be updated?
What variant types should a clinical platform handle natively?
How long does clinical NGS interpretation take with vs without automation?
Keep Reading
Related Resources
Evaluate the Golden Helix Platform
Ready to see the difference between basic tools and a professional clinical NGS platform? No per-sample fees, on-premises or private-cloud deployment, ACMG/AMP automation built in. Start a free evaluation.